-
Featured
Update on the Use of Human Antibody Bamlanivimab to Treat COVID-19: Q&A with Michael Dougan, MD, PhD
In this Q&A, Michael Dougan, MD, explains the interim results of the bamlanivimab clinical trial based on his experience with the trial at Massachusetts General Hospital, what has been learned about the therapy to date and what still needs to be studied for this drug to become a standard of care to treat COVID-19.
-
Featured
COVID-19 Vaccine Candidates
The effort to produce and distribute a SARS-CoV-2 vaccine has made remarkable progress. Currently there are over 180 candidate vaccines against SARS-CoV-2 in development worldwide.
-
Featured
Athletes and COVID-19: Q&A with Sports Cardiologist Meagan Wasfy, MD
The Cardiovascular Performance Program has been treating athletes diagnosed with COVID-19, ranging from those who are asymptomatic to those with persistent symptoms after their infection. Meagan Wasfy, MD, describes the evolution of return-to-play guidelines as we learn about the progression and treatment of COVID-19.
-
A Hybrid Model of In-person and Telemedicine Visits Facilitates Longitudinal Care Delivery
The COVID-19 pandemic has catalyzed widespread usage of telemedicine due to the unprecedented need for remote patient care. Ami Bhatt, MD, discusses operationalizing a hybrid virtual cardiovascular clinic with a traditional in-person clinic in one large academic teaching hospital.
-
Bariatric Surgery in the Time of COVID-19
Earlier this year, clinicians and researchers identified the disease of obesity as a risk factor for serious cases of COVID-19. Matthew M. Hutter, MD, MPH, explores the relationship between obesity and COVID-19, and discusses the benefits of pursuing bariatric surgery in this time.
-
Novel Anticoagulation Protocol to Decrease Hemofilter Clotting in COVID-19 Patients
In a pilot study, Massachusetts General Hospital researchers found that dosing systemic heparin according to anti–factor Xa levels resulted in improved hemofilter life in critically ill COVID-19 patients undergoing continuous venovenous hemofiltration.
COVID-19 contributors
-
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Encapsulated Fecal Microbiota Transplantation Alters Gut Microbiome in Adults with Obesity -
Elizabeth M. Van Cott, MD
Director, Coagulation Laboratory, Massachusetts General Hospital, Professor of Pathology, Harvard Medical School
Recent Article
Pronounced Elevation of Factor V in Severe COVID-19 Is Associated with Venous Thromboembolism -
Erica Seiguer Shenoy, MD, PhD
Associate Physician, Massachusetts General Hospital, Associate Chief of the Infection Control Unit, Massachusetts General Hospital
Recent Article
What Is a Superspreader Event?
-
Galit Alter, PhD
Principal Investigator, Ragon Institute, Massachusetts General Hospital, Samana Cay MGH Research Scholar
Recent Article
Medical Grand Rounds: The Quest for a COVID-19 Vaccine
-
George A. Alba, MD
Pulmonary and Critical Care Physician, Instructor of Medicine at Harvard Medical School
Recent Article
The CORE Clinic and Post-ICU Care: Q&A with Leo Ginns, MD, and George Alba, MD
-
Hanny Al-Samkari, MD
Hematologist
Recent Article
Prothrombin Fragment 1.2 Predicts Thrombosis in Hospitalized Patients with COVID-19
-
Ilona T. Goldfarb, MD
Maternal Fetal Medicine Specialist
Recent Article
Pregnant Women Perceive Benefits of Participating in Vaccine Trials
-
Katrina A. Armstrong, MD
Physician-in-Chief, Department of Medicine, Massachusetts General Hospital
Recent Article
Medical Grand Rounds: COVID-19 Transmission: A State of the State, Our Schools and the NBA
-
Lorenzo Berra, MD
Medical Director, Respiratory Care, Massachusetts General Hospital
Recent Article
Case Series: Inhaled Nitric Oxide for Pregnant Patients with Severe or Critical COVID-19
-
Louise C. Ivers, MD
Executive Director of the Mass General Center for Global Health, Associate Physician in the Division of Infectious Diseases
Recent Article
Medical Grand Rounds: COVID-19 in Low-Resourced Settings—Reaching for Global Health Equity -
Michael L. Dougan, MD, PhD
Physician, Division of Gastroenterology, Massachusetts General Hospital, Director, GI Center for Cancer Complications, Mass General Cancer Center, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Update on the Use of Human Antibody Bamlanivimab to Treat COVID-19: Q&A with Michael Dougan, MD, PhD
-
Rachel P. Rosovsky, MD
Hematologist, PERT Executive Committee Member
Recent Article
Prothrombin Fragment 1.2 Predicts Thrombosis in Hospitalized Patients with COVID-19
-
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
Pulmonary and Critical Care Medicine
The Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital provides comprehensive care for the full range of respiratory conditions and diseases.Related Links
